- Home
- MESA vs CALC Comparison
MESA vs CALC Comparison
Compare MESA & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- CALC
- Stock Information
- Founded
- MESA 1982
- CALC 2011
- Country
- MESA United States
- CALC United States
- Employees
- MESA N/A
- CALC N/A
- Industry
- MESA Air Freight/Delivery Services
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- CALC Health Care
- Exchange
- MESA Nasdaq
- CALC Nasdaq
- Market Cap
- MESA 50.0M
- CALC 48.1M
- IPO Year
- MESA 2018
- CALC N/A
- Fundamental
- Price
- MESA $1.23
- CALC $2.79
- Analyst Decision
- MESA
- CALC Strong Buy
- Analyst Count
- MESA 0
- CALC 2
- Target Price
- MESA N/A
- CALC $14.50
- AVG Volume (30 Days)
- MESA 90.6K
- CALC 37.2K
- Earning Date
- MESA 08-13-2025
- CALC 08-12-2025
- Dividend Yield
- MESA N/A
- CALC N/A
- EPS Growth
- MESA N/A
- CALC N/A
- EPS
- MESA N/A
- CALC N/A
- Revenue
- MESA $406,021,000.00
- CALC N/A
- Revenue This Year
- MESA $39.81
- CALC N/A
- Revenue Next Year
- MESA N/A
- CALC N/A
- P/E Ratio
- MESA N/A
- CALC N/A
- Revenue Growth
- MESA N/A
- CALC N/A
- 52 Week Low
- MESA $0.68
- CALC $1.42
- 52 Week High
- MESA $1.43
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- MESA 70.41
- CALC 53.21
- Support Level
- MESA $1.07
- CALC $2.74
- Resistance Level
- MESA $1.22
- CALC $3.05
- Average True Range (ATR)
- MESA 0.04
- CALC 0.23
- MACD
- MESA 0.01
- CALC -0.02
- Stochastic Oscillator
- MESA 96.94
- CALC 79.51
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.